MedTrace Logo

Ketamine Infusion as a Method of Cerebral Protection in Children

NCT06525584 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2024-07-29

No results posted yet for this study

Summary

The study is devoted to the use of ketamine infusion in a subanesthetic dose in the postoperative period in children after surgical correction of congenital heart defects in children.

Conditions

  • Brain Injuries

Interventions

DRUG

Ketamine Hcl 50Mg/Ml Inj

ketamine infusion at a dose of 0.1 mg/kg/hour for 16 hours

DRUG

Ketamine Hcl 50Mg/Ml Inj

ketamine infusion at a dose of 0.3 mg/kg/hour for 16 hours

OTHER

Control

Without ketamine

Sponsors & Collaborators

  • Kemerovo State Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-05
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06525584 on ClinicalTrials.gov